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 47 
BACKGROUND 48 The prevalence of obesity is increasing worldwide, with a corresponding increase in overweight 49 and obese patients referred with infertility. This systematic review aimed to determine whether 50 non-surgical weight reduction strategies result in an improvement in reproductive parameters 51 affected by obesity, e.g. delayed time to pregnancy, oligozoospermia and azoospermia. No prior 52 reviews have examined this within the general fertility population, or in both sexes. 53 
 54 
OBJECTIVE AND RATIONALE  55 Our objective was to answer the question: “In overweight and obese women, men and couples 56 seeking fertility treatment, what non-surgical weight loss interventions have been used, and 57 how effective are they at weight loss and improving reproductive outcomes?” 58 
 59 
SEARCH METHODS  60 An electronic search of MEDLINE, EMBASE and the Cochrane Library was performed for studies 61 published between (AUTHOR: correct?) January 1966 and March 2016.  Text word and MESH 62 search terms used related to infertility, weight, and barriers to weight loss. Inclusion criteria 63 were: an intervention to change lifestyle evaluated in any study design in participants of either 64 gender with an unfulfilled desire to conceive. Studies were excluded if they included 65 participants not attempting pregnancy, with illnesses that might cause weight fluctuations, or 66 studies evaluating bariatric surgery. Two reviewers performed data extraction and quality 67 
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assessment using the Cochrane Risk of Bias Tool for randomised trials, and a ratified checklist 68 (ReBIP) for non-randomised studies.  69 
 70 
OUTCOMES  71 A total of 40 studies were included, of which 14 were RCTs. Primary outcomes were pregnancy, 72 live birth rate and weight change. In women, reduced calorie diets and exercise interventions 73 were more likely than control interventions to result in pregnancy [Risk Ratio 1.59, 95% CI 74 (1.01, 2.50)], and interventions resulted in weight loss and ovulation improvement, where 75 reported. Miscarriage rates were not reduced by any intervention.  76 
 77 
WIDER IMPLICATIONS   78 Overweight and obese persons seeking fertility should be educated on the detrimental effects of 79 fatness and the benefits of weight reduction, including improvement in pregnancy rates. A 80 combination of a reduced calorie diet, by reducing fat and refined carbohydrate intake, and 81 increased aerobic exercise should form the basis of programmes designed for such individuals. 82 A lack of randomised studies in men and couples, and studies evaluating barriers to undertaking 83 weight loss in infertile populations is evident, and future research should examine these issues 84 further. 85  86 
Key words: infertility, obesity, weight loss, systematic review, diet, exercise 87 
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Introduction 88  89 Overweight is defined by the World Health Organization (WHO)  (World Health Organization, 90 2016) as a BMI ≥ 25 kg/m2, and obesity as ≥ 30 kg/m2. The prevalence of obesity is increasing 91 worldwide (World Health Organization, 2016), with more than 600 million obese adults, 92 including 15% of women, in 2014 - double the prevalence reported three decades earlier. 93 Infertility is defined by the failure to achieve a clinical pregnancy after 12 months or more of 94 regular unprotected sexual intercourse  (Zegers-Hochschild et al., 2009; National Institute for 95 Health and Clinical Excellence, 2013). Using this definition, infertility affects about 1 in 7 96 couples in the UK, which is similar to an estimate of prevalence in the USA  (Thoma et al., 2013). 97 An increasingly overweight and obese population has led to a greater proportion of individuals 98 with high BMI being evaluated in infertility settings (Vahratian and Smith, 2009). 99  100 BMI has been associated with delayed conception in women in a dose-dependent fashion  101 (Gesink Law et al., 2007; Wise et al., 2013; Wise et al., 2010). It is thought to produce 102 anovulation (Zain and Norman, 2008; Klenov and Jungheim, 2014), which results in menstrual 103 irregularity  (Hartz et al., 1979; Zain and Norman, 2008); impairment of oocyte development 104 (Klenov and Jungheim, 2014) and quality  (Carrell et al., 2001; Metwally et al., 2007); and it also 105 has direct effects on the endometrium (Bellver et al., 2011). With ovulation induction (OI) 106 treatment, higher doses of medications  (Dickey et al.; Balen et al., 2006a) and a longer period of 107 stimulation  (Balen et al., 2006b) are required with a higher BMI. With IVF, the chances of 108 achieving a pregnancy decrease with each unit increase in BMI  (Ferlitsch et al., 2004), and it is 109 thought that implantation rates are lower in obese women  (Bellver et al., 2010; Styne-Gross et 110 
al., 2005). An increased risk of miscarriage following IVF has also been reported  (Maheshwari 111 
et al., 2007). 112  113 
 6 
Obesity may affect male fertility in a dose-dependent manner  (Sallmen et al., 2006). Postulated 114 mechanisms include increased testicular temperature with prolonged sitting  (Hammoud et al., 115 2012), and increased oestrogen production in fat with disruption of the hypothalamo-pituitary-116 gonadal axis  (Schneider et al., 1979; Shukla et al., 2014). Some studies have suggested reduced 117 sperm concentration and motility  (Hammiche et al., 2012; Hakonsen et al., 2011; Sermondade 118 
et al., 2013), and lower clinical pregnancy rates with IVF  (Keltz et al., 2010; Umul et al., 2015) 119 with increasing male adiposity. Where both partners are obese, greater difficulty achieving 120 pregnancy is expected  (Ramlau-Hansen et al., 2007). 121  122 Patients attending for fertility treatments are often advised to optimize their weights to 123 improve outcomes, and in some cases to access assistance with funding (National Institute for 124 Health and Clinical Excellence, 2013; Farquhar and Gillett, 2006; Infertility Network UK, 2015) 125 or to reduce the risks of obstetric complications (The Royal Australian and New Zealand College 126 of Obstetricians and Gynaecologists, 2011).  127  128 The purpose of this systematic review was to investigate first whether weight loss interventions 129 for infertile patients achieve their goal in reducing weight, and second whether they result in 130 improved fertility outcomes. A prior systematic review of 11 studies in women (Sim K.A. et al., 131 2014) focussed on assisted reproduction only and used a much more limited search for studies 132 up until 2014. Our review used an extensive search until 2016 and presents data from 40 133 studies with women and men with infertility, not just patients requiring assisted reproduction.  134 135 
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Methods 136  137 This systematic review was undertaken according to a pre-specified protocol.  138  139 
Criteria for considering studies for this review 140 
 141 
Types of studies 142 We included intervention studies in overweight or obese participants with any design and any 143 duration of follow-up. 144   145 
Types of participants 146 Participants could be of either sex. They were required to have both infertility, defined by an 147 unfulfilled desire to conceive of any duration or attendance for infertility investigations or 148 treatment, and a prescribed period of attempt at weight loss.  A BMI ≥ 25 kg/m2 was used to 149 define overweight, and ≥ 30 kg/m2 to define obesity (World Health Organization, 2016); 150 participants were required to be at least overweight. Morbid obesity was defined by BMI ≥ 40 151 kg/m2. Studies were excluded if participants were not actively attempting pregnancy, or had an 152 illness or eating disorder that might result in weight fluctuation. 153 
 154 
Types of interventions 155 Any intervention for weight loss allowed inclusion, for example prompt for weight reduction, 156 dietary modification, exercise, psychological or behavioural counselling, or the drug orlistat. 157 Bariatric surgery was not included. Alternative or control interventions were included where 158 evaluated in included studies. 159 
 160 
Types of outcome measures 161 
 8 
Primary outcomes were weight change, achievement of pregnancy, and live birth, the latter 162 defined as the complete expulsion or extraction from its mother of a product of fertilisation, 163 which, after such separation, breathes or shows any other evidence of life such as heart beat, 164 umbilical cord pulsation, or definite movement of voluntary muscles, irrespective of whether 165 the umbilical cord has been cut or the placenta is attached (National Institute for Health and 166 Clinical Excellence, 2013). 167 
 168 Secondary outcomes were BMI change; waist circumference change  (North American 169 Association for the Study of Obesity et al., 2000); miscarriage, defined as a loss of pregnancy 170 before 23+6 weeks of gestation (Anonymous , 2012); ovulation improvement, with anovulation 171 defined by suboptimal rise in LH, or a below-threshold serum progesterone level taken in the 172 mid-luteal phase of the menstrual cycle (National Institute for Health and Clinical Excellence, 173 2013); improvement in menstrual regularity, with irregular cycles defined as outside the range 174 of 26-36 days (National Institute for Health and Clinical Excellence, 2013); and time to 175 conception. 176  177 
Search methods for identification of studies 178  179 The dates searched were 1 January 1966 to 19 March 2016. No restriction was placed on 180 language of origin, or publication statusand studies could be included regardless of whether 181 they had been published (AUTHOR: please would you clarify what you mean by ‘status’ here?). 182 The electronic databases used were MEDLINE, EMBASE and the Cochrane Library. Additional 183 studies were identified through review of the references of the retrieved papers, contact with 184 study authors, and online searching of Google and Google Scholar (Google Inc., Mountain View, 185 CA, USA). The search strategy used for MEDLINE and EMBASE is given in the Supplementary 186 Data (AUTHOR: we tend not to include Appendices, therefore these data have been divided and 187 renamed as supplementary files.). 188 
Formatted: Font: Bold
Commented [BDA4]: Reworded “publication status for clarity” 
Commented [BDA5]: Thank you 
 9 
 189 
Data collection and analysis 190  191 
Selection of studies 192 The titles and abstracts obtained were screened by one author (DB). To verify the process of 193 selection, the titles and abstracts for the year 2000 were independently screened by DB and AA, 194 with full agreement with respect to papers to be included or excluded. Thus full text versions of 195 all relevant papers were retrieved by DB for further scrutiny by both reviewers. Any 196 disagreement between the two as to which studies to include was resolved by discussion.  197 
 198 
Data collection process 199 Data were extracted by one reviewer (DB), and checked by a second (AA). Discrepancies were 200 resolved by discussion between the reviewers, and a third reviewer (SB) was available for 201 referral as necessary. Study authors were contacted as required for missing data or clarification. 202   203 For each included study, the information collected included study design; methods; location, 204 setting and time period; information about the participants (demographics, infertility diagnosis, 205 BMI, eligibility criteria); drop-outs; the types of interventions assessed and their descriptions; 206 and outcomes, including pregnancy, live births, weight or BMI change, miscarriage, ovulation 207 and menstrual change. For men, semen analysis parameters were captured. (AUTHOR: please 208 would you re-state those outcomes here, for clarity? Thank you.). Any data on barriers to weight 209 loss were also captured. Data on costs and cost-effectiveness were sought but not found. 210 
 211 
Assessment of risk of bias in individual studies 212 RCTs were assessed for their methodological quality using the Cochrane Risk of Bias Tool  213 (Higgins et al., 2011). 214  215 
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Non-randomised studies were assessed using a checklist developed for the Review Body for 216 Interventional Procedures (ReBIP) (64)(AUTHOR: please would you use the correct format of 217 citation?). The ReBIP is an independent review body that carries out systematic reviews for the 218 National Institute for Health and Care Excellence’s Interventional Procedures Programme. The 219 checklist was adapted from several sources  (Verhagen et al., 1998; Khan et al., 2001; Downs 220 and Black, 1998), and has been used in many systematic reviews. It includes assessment of 221 sample selection; clarity of inclusion and exclusion criteria; baseline comparability of 222 participants; consecutive selection of patients; prospective data collection; clarity of 223 intervention descriptions; experience of person administering the intervention; 224 appropriateness of staff, place and facilities where participants were treated; consideration of 225 important incomes on clinical effectiveness, cost-effectiveness, or learning curves; use of 226 objective outcome measures; blinding of outcome assessment; adequacy of duration of follow-227 up to detect important effects on outcomes of interest; information provision on dropouts, and 228 their similarity to completers; identification of important prognostic factors; and adjustment of 229 analyses for confounding factors.  230  231 
Summary measures 232 Results were summarised descriptively. In the outcome summary tables, numbered rankings 233 are provided in an effort to demonstrate which study interventions reported more favourable 234 outcomes, with a lower number indicating a better outcome. Meta-analysis was undertaken 235 where possible. Risk ratios (RR) and mean differences with 95% CI between groups are 236 reported. 237 
 238 
Synthesis of results 239 Data were imported into Review Manager Version 5.3.5 (The Cochrane Collaboration, Oxford, 240 UK) for quantitative synthesis. A random effects, rather than a fixed effect model, was used for 241 
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meta-analysis, owing to unavoidable population and intervention heterogeneity, as anticipated 242 in interventions for weight loss. 243 
 244 
Assessment of heterogeneity 245 Statistical heterogeneity was investigated by visual inspection of forest plots, the Q-test (with 246 p<0.1 implying statistical heterogeneity) and by examining the I2 statistic (Higgins and 247 Thompson, 2002), where a result >50% was taken to indicate substantial statistical 248 heterogeneity. 249 
 250 
Sensitivity analyses 251 Sensitivity analysis was planned to compare randomised trials judged to be at low risk of bias 252 for allocation concealment or randomisation with those judged to be at higher risk of bias; 253 however, the small numbers of trials precluded this.  254 
 12 
Results 255 
 256 
Outcome of the search 257  258 Details of the selection process for studies is summarised in the PRISMA flow diagram (Figure 259 1) (AUTHOR: the quality of this figure still seems poor. If possible, please can you send to me a 260 higher quality file?). Seventeen study authors were contacted for clarification or further 261 information; ten provided helpful further information.  262  263 Full details of all the studies and interventions are provided in Supplementary Table SI. There 264 were 14 RCTs, six non-randomised studies with comparison groups (NRCTs), and twenty cohort 265 studies with interventions. Ten studies took place in Australia, seven in the USA, three each in 266 Italy and the Netherlands, and two in Denmark. One each came from Belgium, Brazil, Canada, 267 Egypt, France, Germany, India, Iran, Jordan, Pakistan, Russia, Saudi Arabia, Slovakia, Turkey and 268 the UK. Three studies were multi-centre. 269  270 Enrolment varied from eight participants  (Faure et al., 2014) to 577  (Mutsaerts et al., 2016). 271 Attrition rates ranged from 10.6%  (Mutsaerts et al., 2016) to 66.7%  (Turner-McGrievy et al., 272 2014). 273 
 274 
Description of populations 275 
 276 Mean age of study groups varied from 25 years  (Lazurova et al., 2004) to 35.4 years  (Chavarro 277 
et al., 2012). Ethnicity was reported in six papers, with between 55%  (Turner-McGrievy et al., 278 2014) and 87.5% white  (Mutsaerts et al., 2016). 279  280 
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Duration of infertility, where reported, ranged from a mean of 19.5 months  (Palomba et al., 281 2008) to 11 years  (Aliyeva et al., 1993). Some studies addressed women with any infertility 282 history. Others centred on women undergoing fertility treatments or planning to start 283 immediately following the intervention. Some were exclusively catered to persons with 284 polycystic ovary syndrome (PCOS), with the syndrome defined by Rotterdam 2004 consensus 285 criteria (ESHRE and Group, ASRM-Sponsored PCOS Consensus Workshop, 2004) in ten cases, 286 National Institutes of Health (NIH) criteria (Zawadzki and Dunaif, 1992) in one case, ultrasound 287 appearance of the ovaries in two cases, and not specified in five cases. One study used PCOS as 288 an exclusion criterion  (Moran et al., 2003).  289  290 In eight studies, patients were anovulatory, and in seven studies patients had irregular 291 menstrual cycles. Three papers were centred on patients who were resistant to clomiphene 292 citrate for ovulation induction. 293  294 The lowest mean BMI was 24.5 kg/m2  (Chavarro et al., 2012), and the highest was 44 kg/m2  295 (Mahoney, 2014; Hakonsen et al., 2011). 296  297 Two studies were centred on men. One had participants with sperm DNA fragmentation who 298 were overweight or obese  (Faure et al., 2014), while the other examined obese men only  299 (Hakonsen et al., 2011). One study examined a weight loss intervention in couples  (Homan et 300 
al., 2012). 301 
 302 
Description of interventions 303 
 304 Table 1 provides brief details of the types of interventions tested. In general, interventions were 305 poorly described, with insufficient detail to allow their replication. Where described, most 306 reducing diets followed healthy eating principles by reducing fat and refined carbohydrate 307 
 14 
intake. Where available, studies described calorie intakes ranging from 1000 to 2000kcal/d 308 (depending on body size), apart from three studies that tested very low calorie diets as part of 309 their reducing diets (Tsagereli 2006, Kiddy 1992, van Dam 2004) and one that tested a very low 310 carbohydrate ketogenic diet (Mavroupolos 2005). If physical activity advice or programmes 311 were incorporated into interventions, they were generally for aerobic exercise. There was no 312 clear evidence that any particular regime was more effective for weight loss, providing there 313 was a weight reduction diet prescribed.  314  315 Five of the 16 interventions incorporating both a dietary and physical activity component 316 provided some part of the intervention in a group setting. Only two interventions were 317 described involving couples.  One study  (Chavarro et al., 2012) tracked participants’ weights 318 after administering a lifestyle questionnaire. While this is not strictly a weight-loss intervention, 319 we have included it with the other cohort studies, because there is evidence that weight loss 320 occurs with enrolment in studies tracking weight, even with minimal intervention (Waters et al., 321 2012; Johns et al., 2016). 322  323  324 
Quality of studies 325  326 The quality of the studies included was variable. For full details of risk of bias assessment for all 327 the randomised studies please see Supplementary Table SII. The quality of the studies included 328 was variable. Three of fourteen RCTs had four or five out of seven domains with low risk of bias, 329 e.g. allocation concealment, incomplete outcome data, but the Lifestyle trial (Mutsaerts et al., 330 2016) stood out as the one with best quality. All studies were of high risk of bias with respect to 331 blinding of participants to treatment allocation, and all had low risk of bias in at least two 332 domains. Five of 26 non-randomised studies, having eight to nine of 14 domains with low risk of 333 
 15 
bias, were judged to be good quality. Full details of the risk of bias assessment for the non-334 randomised studies are given in Supplementary Table SIII. 335  336 
Studies involving female infertility participants 337 
 338 
Pregnancy 339 Aggregated data from six RCTs show that women who received a combination of a reducing diet 340 and exercise had higher pregnancy rates than those who underwent standard care(AUTHOR: is 341 there a word missing? Please would you recheck the sense here? Thank you.), 238/434 (54.8%) 342 versus 221/443 (49.9%); RR 1.59, 95% CI (1.01, 2.50) (Figure 2). The trial by Mutsaerts et al  343 (2016) ) contributed significantly to the heterogeneity, I2=71% and its exclusion in a post-hoc 344 sensitivity analysis reduced I2 to 0%. Although the numbers of participants in other RCTs were 345 too few for any meaningful conclusions to be drawn, a very small trial was unable to 346 demonstrate any advantage of diet alone, while another suggested that orlistat might be 347 beneficial.  The results of an NRCT (Clark et al, 1998) support the result of the meta-analysis 348 favouring diet and exercise.  The study by Koning et al (2015)  did not show any advantage 349 associated with motivational interviewing.350 
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Table 2 details the reproductive outcomes for all included studies. Diet and exercise studies 351 without control populations achieved rates that were comparable to those included in the meta-352 analysis. 353 
 354 
Live births  355 Data from five RCTs (Figure 3) did not favour diet and exercise over standard care in terms of 356 live birth rates which were 48.9% (195/399) versus 46.8% (190/406) respectively; RR 1.54, 357 95% CI (0.93, 2.56). Mutsaerts et al  (Mutsaerts et al., 2016) again contributed significantly to 358 the heterogeneity, I2=69%. Its exclusion in a post-hoc sensitivity analysis reduced I2 to 0%, and 359 resulted in diet and exercise having a statistical advantage, RR 1.86, 95% CI (1.25, 2.77). The 360 NRCT  (Clark et al., 1995; Clark et al., 1998) also favoured the intervention arm, 45/67 (67.2%) 361 versus no treatment (0/20); RR 28.10, 95% CI (1.81, 436.85). Motivational interviewing was 362 also not associated with an increased live birth rate. 363   364 Table 2 details live birth rates for all included studies. Women in studies on diet and exercise 365 without control groups had lower success rates than those included in the meta-analysis. 366 Khaskheli et al  (Khaskheli et al., 2013), who did not provide details of their intervention, 367 reported a 37.6% (32/85) livebirth rate, while Crosignani et al,  (Crosignani et al., 2003), who 368 administered a 1200 kcal/day diet along with aerobic exercise, achieved a 24.2% (8/33) rate. 369 The numbers of participants in the other studies included in Table 2 were too few for any 370 meaningful conclusions to be drawn.371 
 17 
Spontaneous and IVF conceptions  372 Pooled data from RCTs (Figures 4 and 5) show that, reducing diets and exercise were not 373 associated with a higher chance of spontaneous conception [28.3% (86/304) versus 15.9% 374 (50/315); RR 2.20, 95% CI (0.98, 4.93)].  375 
 376 
Miscarriages  377 A combination of a reducing diet and exercise was associated with a pooled miscarriage rate of 378 13.4 per hundred women (48/357) or 23.3% of pregnancies (48/206) (Figures 6 and 7).  The 379 control arm had a pooled miscarriage rate of 8.7 per hundred women (31/355) or 15.6% of 380 pregnancies (31/199). This shows no benefit of diet and exercise [combined RR 0.96, 95% CI 381 (0.89, 1.04) per woman and RR 0.91, 95% CI (0.91, 0.82, 1.01) per pregnancy]. Miscarriage rates 382 in the other studies on diet and exercise vary widely (Table 2). 383 
 384 
Ovulation 385 One RCT  (Palomba et al., 2010) found a 37.5% (12/32) ovulation improvement with a 386 combination of reducing diet and exercise, while its control group had a 9.3% (3/32) 387 improvement rate; RR 4.00 95% CI (1.25, 12.84) (Figure 8). An NRCT, also using diet and 388 exercise, that had the highest rate of improvement of all included studies in its intervention 389 group (AUTHOR: again, does this sentence read correctly? Please would you recheck?), 89.6% 390 (60/67), while none of the participants in the control group saw improvement; RR 37.37, 95% 391 CI (2.41, 578.65). 392  393 One RCT (Kumar and Arora, 2014) compared the use of 120mg of orlistat twice daily and a 394 lifestyle modification programme with use of the lifestyle programme alone. The orlistat group 395 had a 50% (15/30) rate of ovulation, while the control group had a 6.7% (2/30) rate; RR 7.50, 396 95% CI (1.88, 29.99). 397  398 
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One RCT  (Legro et al., 2015) compared the proportions of total clomiphene treatment cycles 399 that were ovulatory in each group. The group whose treatment was preceded by diet and 400 exercise advice and the oral conceptive pill (OCP) had the best ovulation rate, 67.1% (94/140), 401 while the lifestyle alone group and control (OCP alone) group had rates of 60.3% (82/136) and 402 46.1% (71/154) respectively. 403  404 Another RCT  (Thomson et al., 2008) randomised its participants, who had PCOS, to receive an 405 energy-restricted high-protein diet alone (DO), combined with aerobic exercise (DA), or 406 combined with both aerobic and resistance exercise (DC). DO saw a 50% (6/12) improvement 407 in ovulation, DA a 50% (3/6) improvement, and DC a 42.8% (3/7) improvement. 408 
 409 Table 2 shows the ovulation rates in cohort studies of diet without controls. One study using a 410 very low calorie diet  (van Dam et al., 2004) had a relatively good ovulation improvement rate, 411 60% (9/15). Other studies had comparatively low rates, including one using a hypocaloric 1434 412 kcal/day diet  (Thomson et al., 2009) which achieved a 19.2% (10/52) rate, and another  413 (Turner-McGrievy et al., 2014) which saw no improvement using either an low-calorie diet 414 (LCD) (AUTHOR: please define LCD) or a vegan diet. One study compared a hypocaloric high 415 protein diet to structured exercise training (SET)  (Palomba et al., 2008), and achieved a 25% 416 (5/20) improvement rate with diet, and a 65% (13/20) improvement with exercise. 417 
 418 A study comparing ovulation improvement in women receiving acupuncture to those receiving 419 an unspecified diet  (Aliyeva et al., 1993) had a 55% (11/20) improvement with the former, and 420 46.7% (28/60) improvement in the latter; RR 1.18, 95% CI (0.73, 1.90). 421 
 422 
Menstrual irregularity  423 In clomiphene citrate resistant PCOS women, a single trial  (Palomba et al., 2010), showed that 424 hypocaloric diet and exercise was significantly more likely to result in menstrual improvement, 425 
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than observation only: 34.4% (11/32) versus 9.3% (3/32); RR 3.67, 95% CI (1.13, 11.92) 426 (Figure 9). Other studies without control groups also suggest that diet and exercise were 427 associated with improvement in menstrual regularity (Table 2). There were no RCTs evaluating 428 the role of dietary interventions alone or motivational interviewing in regulating menstrual 429 cyclicity. Data from observational and often uncontrolled studies of other interventions show 430 variable levels of success (Table 2). 431 
 432 
Oocyte retrieval  433 Data from a single RCT (Figure 10) suggest that a low glycaemic index diet  (Becker et al., 2015) 434 could improve oocyte yield in IVF. The mean (SD) number of oocytes in women in the 435 intervention arm was 7.75 (5.39), compared to 4.18 (SD 3.01) in controls; mean difference -436 3.57, 95% CI (-6.87, -0.27).  437 
 438 
Time to conception  439 The Lifestyle trial  (Mutsaerts et al., 2016) reported that the median time to conception (TTC) 440 resulting in a term live birth was 7.2 months (interquartile range (IQR) 2.6, 12.0) in the 441 intervention group, who underwent a multidisciplinary programme based on diet and exercise, 442 versus 5.2 (IQR 2.4, 10.1) in the control group, who were allowed fertility treatment from the 443 start (P=0.06). An RCT comparing energy-restricted low protein and high protein diet groups 444 who both received exercise instruction  (Moran et al., 2003) reported a 4-5 week TTC regardless 445 of group. A cohort study which advised women to lose 10% of their body weight  (Kort et al., 446 2013; Kort et al., 2014) found that those who met the target had a mean TTC of 227 days, while 447 those who had not had a mean of 231 days. 448 
 449 
Weight loss  450 Aggregated data from RCTs suggest that a combination of a reducing diet and exercise resulted 451 in greater weight loss than that achieved in control groups (Figure 11); mean difference -3.98 kg 452 
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(95% CI -4.85, -3.12). Diet alone was also shown to be more effective in a small RCT; mean 453 difference -5.23kg (95% CI -7.42, -3.04) (Becker et al., 2015).  454  455 In non-randomised trials, Clark et al  (Clark et al., 1998) reported significantly greater weight 456 loss from diet and exercise; mean difference -9.00kg (95% CI -10.88, -7.12). Two non-457 randomised trials testing motivational interviewing also found greater weight loss; mean 458 difference -3.21kg (95% CI -5.93, -0.49kg). Changes in weight, BMI and waist circumference for 459 other studies are provided in Table 3. Generally results are not inconsistent with studies with 460 either randomised or non-randomised control groups. 461  462 
Comparisons with metformin 463 
 464 
Pregnancy  465 Three small RCTs evaluated lifestyle interventions versus metformin (Figure 12). None was able 466 to show any superiority of metformin over the alternative intervention, but it is difficult to be 467 confident about these outcomes owing to the small sample sizes involved. 468  469 
Ovulation  470 
Two small RCT of diet or drug treatment (Figure 13) were unable to show any benefit over 471 
metformin. Details of other studies are in Table 2. 472  473 
Menstrual irregularity  474 Metformin did not appear to improve menstrual regularity in a number of small trials 475 comparing it to diet and exercise with or without drug treatment, diet alone or acarbose (Figure 476 14). Details of other studies are in Table 2. 477 
 478 
Weight loss 479 
 21 
Weight, BMI and waist circumference changes for studies comparing metformin with lifestyle 480 interventions are provided in Table 3. 481 
AUTHOR: please would you mention Supplementary Table SIII (Quality assessment for non-482 
randomised studies) at the appropriate place in the Results section? (Please renumber the 483 Supplementary Tables if order in text requires it.) Thank you. 484 
Summary of the key findings in infertile women 485  486 In overweight and obese infertile women, weight loss is associated with improved chances of 487 becoming pregnant, and possibly spontaneous conception pre-IVF. Ovulation and menstrual 488 irregularity are also aided. There appears to be no significant difference between weight loss 489 interventions and controls with respect to rates of miscarriage and IVF conceptions. The few 490 studies that included metformin showed no significant difference between weight loss 491 interventions and the drug for achieving pregnancy or improvement in ovulation status; 492 similarly there was no difference between the two groups in menstrual improvement. 493  494 
Barriers to weight loss in infertile women  495  496 Very little has been reported regarding the perceived barriers to weight loss in overweight and 497 obese infertile women. Two of the included studies attempted in some way to evaluate these.  498 In the trial by Thomson et al  (Thomson et al., 2008), 104 participants were allocated to receive 499 an energy restricted diet only (DO), the same diet combined with five sessions of aerobic 500 walking and jogging exercise per week (DA), or the diet combined with aerobic and resistance 501 training exercises (DC), where resistance exercise replaced two of the aerobic sessions (110) 502 (AUTHOR: please would you use the correct format for the citation? Thank you.). Forty-three of 503 the participants in the trial (DO=13, DA=11 and DC=19) completed a validated Exercise 504 Benefits/Barriers Scale at weeks 0, 10 and 20  (Thomson et al., 2016). This was to determine 505 their perceptions of the benefits and barriers to participation in exercise. The scale included 43 506 
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items with statements related to ideas about exercise and a four-point Likert scale, with 4 = 507 strongly agree, 3 = agree, 2 = disagree and 1 = strongly disagree. At baseline, the statements 508 with the highest agreement were: “exercise tires me” [mean (SD), 2.86 (0.71)]; “exercise is hard 509 work for me [2.79 (0.67)], and “I am fatigued by exercise” [2.60 (0.62)]. Those with the lowest 510 agreement were: “my family members do not encourage me to exercise” [1.56 (0.59)], “my 511 spouse does not encourage exercising” [1.63 (0.70)], and “I think people in exercise clothes look 512 funny” [1.72 (0.59)].  513  514 Barrier scores were reduced by week 10 in this study, regardless of treatment allocation, with 515 
no further reduction by week 20 (P≤0. 001). Time expenditure and physical exertion as 516 perceived barriers saw a significant reduction (P≤0.003), while family discouragement saw no 517 change (P=0.6).  518  519 Participants in the study by Galletly et al  (Galletly et al., 1996), in addition to completing a 24-520 week programme with weekly meetings comprising 1 hour of exercise and 1 hour of dietary and 521 psychiatric counselling, completed the Rosenberg Self-Esteem Scale and the General Hospital 522 Anxiety and Depression Scale at the start and end of the study. At baseline, those who dropped 523 out before the end of intervention exhibited higher anxiety (p<0.02) and depression scores 524 (p<0.069), and lower self-esteem scores (p<0.056) than those who completed. Completion was 525 associated with a significant improvement in self-esteem (p<0.0001) and depression (p<0.006), 526 and a non-significant reduction in anxiety scores.  527  528 Based on what little evidence is available, overweight infertile women appear most deterred 529 from exercise by the perception that it causes fatigue and is hard work. These perceptions, as 530 well as depression, seem to decrease with continuation of an exercise programme. Very few 531 women seem to be discouraged from exercise by family members. Those women who 532 discontinue exercise would appear to be more anxious and/or depressed at the outset. 533 
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 534 
Studies involving male infertility participants  535  536 
Achievement of pregnancy, live birth rate, and Improvement in sperm DNA integrity 537 One cohort study  (Faure et al., 2014) administered a nutritionist-led personalised dietary 538 programme of an unreported nature coupled with exercise, aimed at reducing intra-abdominal 539 fat over a 3-8 month period, to eight men who had significant abdominal fat and at least 25% 540 sperm DNA fragmentation and unexplained infertility (Table 4). The partners of all eight 541 achieved pregnancy, three naturally and five through IUI, and all went on to have live births. Six 542 who allowed their semen samples to be analysed both before and after the intervention all had 543 an improvement in the degree of sperm DNA fragmentation. 544  545 
AUTHOR: could the following sections be edited to avoid repeating most of the data that are 546 shown in Table 4, as we try to minimise such repetition in the results section? Thank you. 547 
Improvement in semen analysis parameters 548 A cohort of 44 men with BMI 33-61 kg/m2 underwent a programme based on a healthy diet and 549 daily exercise  (Hakonsen et al., 2011). Semen analyses before and afterward were compared in 550 27 men, and the results were as shown in Table 4.. 551  552 The group with 3.5-12.1% weight loss (Group 1, n=9) saw a mean change in sperm 553 concentration of -11 million/ml (95% CI -49, +27). The group with 12.2-17.1% (Group 2, n=9) 554 loss had a mean change of +19 million/ml (95% CI -23, 61). The group with 17.2-25.4% loss 555 (Group 3, n=9) had a mean change of +17million/ml (95% CI -24, 58). 556  557 Group 1 saw a mean change in progressive sperm motility of -2%, 95% CI (-15,11). Group 2 had 558 a mean change +4%, 95% CI (-10, 18). Group 3 had a mean change +11%, 95% CI (-3, 25). 559  560 
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Group 1 saw a mean change in normal sperm morphology of 0%, 95% CI (-2, 4). Group 2 had a 561 mean change of +1%, 95% CI (-3, 4). Group 3 had s mean change of +4%, 95% CI (1,7). 562  563 
Change in weight 564 The cohort study by Hakonsen et al  (Hakonsen et al., 2011) achieved median weight change -565 22kg, range -4 to -39 kg. The cohort study by Faure et al  (Faure et al., 2014) achieved a mean 566 weight reduction of -4.40 (SD 5.0 kg).Table 4 also summarises the weight loss achieved in both 567 studies. 568  569 
Summary  570 The relative paucity of studies in overweight and obese men seeking fertility has made it 571 difficult to draw firm conclusions regarding the benefits of weight loss. However, improvements 572 in sperm concentrations, motility and normal morphology have been suggested, though these 573 have not been statistically significant. Improvement in sperm DNA integrity has also been 574 suggested, and this might be linked to an improved live birth rate.  575 576 
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Discussion 577 
 578 
Key findings 579  580 
The present systematic review and meta-analysis found that the weight loss interventions, 581 particularly diet and exercise, improved pregnancy rates and ovulatory status. A trend toward 582 more natural pregnancies, but not IVF pregnancies, occurred. Miscarriage rates were unaffected 583 by weight loss interventions and, as reports of higher oocyte yield and improved menstrual 584 regularity are based on single trials, further research is needed before firm conclusions can be 585 made. A lack of RCTs in men and couples, and of studies evaluating barriers to undertaking 586 weight loss in overweight and obese infertile populations, is evident. The quality of the studies 587 we included was variable, but the one with the lowest risk of bias was the Lifestyle trial  588 (Mutsaerts et al., 2016), whose intervention also ranked highly for both pregnancy and live 589 birth rates. 590  591 
Women 592 
 593 
Pregnancies and live births 594 Weight loss interventions, particularly those with reducing diets and exercise, were more likely 595 than controls to result in pregnancy. Live births were reported by only a fewrelatively fewerer 596 studies (AUTHOR: correct?), usually involving women undergoing fertility treatments such as 597 OI or IVF. Data from studies predating the Lifestyle trial in 2016  (Mutsaerts et al., 2016) 598 suggested that diet and exercise combinations were superior to standard care, but inclusion of 599 this trial changed this. Those in the intervention arm underwent a 6-month programme based 600 on diet and exercise, prior to undergoing 18 months of fertility treatments. Those in the control 601 arm commenced fertility treatments immediately. The primary outcome was vaginal birth of a 602 healthy singleton of at least 37 weeks’ gestation within 24 months after randomisation. The trial 603 
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was well conducted, with low risk of bias. This was the largest study in the review, and it carried 604 substantial weight during meta-analysis. The results deviated from the trend exhibited by the 605 preceding trials, resulting in marked increase in heterogeneity. It is possible that the results 606 might have been different if the control group underwent 6 months of no intervention 607 observation prior to 18 months of treatment. The trial found that significantly more women in 608 the intervention group had ongoing pregnancies from natural (AUTHOR: the term natural’ is 609 usually preferred throughout but I leave the final decision to you.) conception than the control 610 group, consistent with our other findings. 611 
 612 Studies reporting the highest pregnancy and live birth rates were not necessarily those with 613 highest weight loss. Clark et al, had a high live birth rate of 67.2% in the diet and exercise arm of 614 their NRCT, while also achieving one of the highest weight changes, mean -10.2kg (SD 4.3)  615 (Clark et al., 1995; Clark et al., 1998). On the other hand, the intervention arm of the Mutsaerts 616 et al (2016) RCT reported a live birth rate of 53.2%, but only achieved a mean weight change of 617 -4.4 kg (SD 5.8).  618 
 619 
Miscarriages 620 Studies with some of the lowest rates of weight loss reported fewer miscarriages in their 621 intervention arms, but the data are insufficient to draw conclusions (Tables 2 and 3).  622 
 623 
Ovulation 624 Weight loss interventions, regardless of their nature, were significantly more likely than control 625 interventions to achieve ovulation in anovulatory women. Improvements were not necessarily 626 greatest in those studies achieving the greatest weight loss.  627 
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 628 
Menstrual irregularity 629 A single RCT suggested that diet and exercise were significantly more likely to improve 630 menstrual cycles than a control intervention  (Palomba et al., 2010). High rates of menstrual 631 improvement were seen in studies with good weight or BMI reduction. Qublan et al  ( 2007), for 632 example, with a 1200-1400 kcal diet in their RCT, had a 61.9% menstrual improvement and 633 achieved one of the better BMI reductions, with a mean change of -4.8 kg/m2. 634 
 635 
Spontaneous and IVF conceptions 636 Studies included women expected to proceed to in-vitro treatments after a period of weight 637 loss. Many women were able to conceive without further assistance through weight loss alone. 638 All interventions showed an improved rate of spontaneous conception in comparison to a 639 control. There was however no significant difference between interventions and controls when 640 it came to IVF conceptions. Similar spontaneous conception rates were seen regardless of type 641 of intervention and/or amount of weight lost. 642 
 643 
Change in weight, BMI and waist circumference 644 No class of intervention was consistently better in achieving reduction in weight compared to 645 others. Trials with longer interventions and follow-up sometimes suffered from higher rates of 646 study drop-out, for example 20.4% in the 12-month Sim et al RCT  (Sim et al., 2014a) and 10.6% 647 in the 6-month Mutsaerts et al RCT  (Mutsaerts et al., 2016), both of which mainly had diet and 648 exercise. Others had no dropout: Karlsen et al after 7-8 months  (Karlsen et al., 2013) and 649 Koning et al after 6 months (Koning, 2015), and both included motivational interviewing. This 650 suggests that enhancing motivation plays a key role in compliance. Programmes with strict 651 dietary and exercise modifications may be more likely to see discontinuation. The study with 652 the most weight lost, the cohort study by Mavropoulos et al  (Mavropoulos et al., 2005), utilised 653 
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a very restrictive diet for 6 months, and had very low recruitment (n=11) and a high rate of 654 drop-out (58.5%). 655 
 656 
Metformin 657 The meta-analyses showed that weight loss interventions have a non-significant advantage over 658 metformin with respect to achievement of pregnancy or improvement of ovulation status. There 659 was also no significant difference in menstrual regularity improvement. In light of these 660 findings, and the gastro-intestinal side-effects common with metformin  (Kumar and Arora, 661 2014; Qublan et al., 2007), lifestyle interventions should remain the first line therapy for 662 improvement in ovulation and menstruation. 663 
 664 
Interventions in infertile men 665  666 There was very little evidence available to judge the effectiveness of weight reduction strategies 667 in men, and this is an area ripe for future research. The two studies both utilised a diet and 668 exercise combination, with neither providing adequate details of the intervention. 669 
 670 
Types of diet 671  672 As expected, the dietary interventions used were based on caloric restriction, and were usually 673 consistent with weight reduction advice from national guidelines (National Clinical Guideline 674 Centre, 2014; Dietz et al., 2015). It is hard to say, based on the data obtained, whether any 675 particular degree of restriction was superior for achievement of weight loss, particularly given 676 the frequent pairing of diet with exercise. Some of the RCTs used individualized diets, tailoring 677 caloric deficit to baseline weight  (Becker et al., 2015; Duval et al., 2015b). Others mentioned a 678 hypocaloric range within which dietary intakes would fall  (Kumar and Arora, 2014; Qublan et 679 
al., 2007; Thomson et al., 2008; Turner-McGrievy et al., 2014), generally between 1200 and 680 
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1800 kcal/day. Dieticians were used to assist with dietary advice in a few cases  (Duval et al., 681 2015b; Turner-McGrievy et al., 2014; Thomson et al., 2008; Mutsaerts et al., 2016). The RCT 682 with the lowest recruitment and highest discontinuation rate used a vegan diet in one of its 683 study arms  (Turner-McGrievy et al., 2014), suggesting poor acceptance. 684 
 685 
Types of exercise 686  687 The majority of exercise interventions sought to increase weekly aerobic activity in participants 688 in order to increase caloric expenditure. The most frequent feature seen in the RCTs was an 689 increase in the number of steps or amount of walking by participants  (Duval et al., 2015b; 690 Karimzadeh and Javedani, 2010; Legro et al., 2015; Mutsaerts et al., 2016; Sim et al., 2014a; 691 Thomson et al., 2008). Fewer RCTs (AUTHOR: correct, or studies?) included strength or 692 resistance training  (Karimzadeh and Javedani, 2010; Moran et al., 2011b; Thomson et al., 2008), 693 and this was always in addition to the basic aerobic approach. Thomson et al found that 694 addition of resistance training did not result in a significantly different weight loss in their RCT 695 of diet alone, diet with aerobic exercise, or diet with aerobic and resistance exercise  (Thomson 696 
et al., 2008). Physical activity interventions were in some cases individualised  (Duval et al., 697 2015a; Moran et al., 2011a) and in others in the form of group sessions  (Moran et al., 2003), 698 with occasional use of a kinesiologist  (Duval et al., 2015a) or physiotherapist (Kumar and 699 Arora, 2014). 700 
 701 
Types of weight loss medication 702  703 The use of weight loss drugs is contraindicated during pregnancy (Department of Veterans 704 Affairs, 2014), and the studies using them aimed to reduce weight prior to attempting 705 pregnancy. One trial  (Legro et al., 2015) recommended barrier contraception during its 706 intervention. Oral medications used in the studies included orlistat, a lipase inhibitor; 707 
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sibutramine, a selective serotonin and norepinephrine reuptake inhibitor; and acarbose, an 708 alpha-glucosidase inhibitor shown to induce modest weight loss, though not suitable for weight 709 maintenance  (Hauner et al., 2001). Of these, sibutramine, which has been withdrawn in Europe 710 and the USA but is still available on the internet, has been shown in a large study to have a risk 711 of cardiovascular defects in unborn infants (Källén, 2014), while the same study showed no risk 712 of birth defects from orlistat use. The safety of acarbose in pregnancy is not established. Orlistat 713 was shown to be superior to a control with respect to achievement of pregnancy and ovulation 714 in a single study (Kumar and Arora, 2014). Until further evidence is available, lifestyle 715 interventions should still be considered thefirst line therapy, with drug use reserved for 716 monitored trials. 717 
 718 
Strengths and limitations of the review 719  720 This review has added to the scope of the systematic review by Sim et al  (2014b) by going 721 beyond examining overweight and obese women undergoing fertility treatment to encompass 722 individuals of both genders, and couples, from a variety of infertility circumstances undergoing 723 non-surgical weight loss programmes. A wide search strategy meant that we were thus able to 724 capture 40 studies, in comparison to the 11 in that review  (Sim et al., 2014b). Author contact, 725 initiated with 17 study authors, was another strength, as this allowed unreported information 726 to be gained, and clarification of unclear information. Nevertheless, we cannot exclude 727 publication bias, where studies with less positive outcomes remain unreported. 728 
 729 
Clinical recommendations 730  731 Overweight and obese persons seeking fertility should be educated on the effects of being 732 overweight or obese on the ability to achieve pregnancy, and the benefits of weight reduction, 733 including improvement in pregnancy rates, and a reduced need for OI and IVF.  734 
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 735 A combination of a reduced calorie diet, which is not overly restrictive, and aerobic exercise, 736 intensified gradually, should form the basis of programmes designed for such individuals. As 737 compliance is key to success, coached sessions of achievable frequency, e.g. weekly, for up to 6 738 months, should be considered. Motivational interviewing techniques might also be useful. An 739 advantage of fertility care is that couples are catered to, and dual enrolment may result in better 740 adherence, as partners tend to motivate each other. 741 
 742 
Research recommendations 743  744 Future research would ideally be in the form of large multi-centre RCTs including both women 745 and men, ideally couples, attending fertility clinics and having at least one partner with a BMI 746 within the overweight or obese range. Based on the data from RCTs of diet and exercise 747 examined here, we estimate that a trial would require over 454 participants to detect a 748 difference of 15% in pregnancy rates (90% power, p < 0.05, control pregnancy rate 50%, 749 intervention rate 65%). This figure does not take account of losses to follow-up, and would need 750 to be considerably inflated, depending on drop-out rates in feasibility and pilot work.  751  752 A reasonable control intervention would be the administration of dietary and exercise advice 753 only , to be undertaken for a brief period only (AUTHOR: correct?), to reduce persons allocated 754 to this arm feeling as though their fertility treatments were being delayed with no intervention. 755 Similar durations employed between intervention and control groups prior to starting fertility 756 treatments would allow for fair comparisons with respect to weight loss and reproductive 757 outcomes.  758  759 A long duration of follow-up, spanning decades, might answer further questions, including 760 whether obstetric problems related to weight such as gestational diabetes or caesarean rates 761 
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might be reduced in imminent or future pregnancies. The permanency of lifestyle changes made 762 while attempting fertility might also be established, as well as their impact on family members, 763 and the maintenance of weight loss in the long term. The role of epigenetic changes might also 764 be explored (AUTHOR: although important, and you are discussing possible future research 765 here, this subject has not been mentioned so far and seems a little unrelated to the overall 766 approach here. It is also unclear what particular studies you would perform, therefore I suggest 767 removing it, which would not detract from the discussion. If you agree, please edit accordingly? 768 Thank you.). 769 
 770 
Conclusions 771  772 Non-surgical weight reduction strategies in the infertile have been shown to improve 773 reproductive outcomes in both men and women. Diet, exercise, a combination of the two, 774 weight-loss medication and motivational interviewing have all been efficacious in reducing 775 obesity. In women, weight loss from diet and exercise is associated with improved chances of 776 becoming pregnant, with a trend toward improved live birth rate. Ovulation and menstrual 777 irregularity are also aided. At present there appears to be no significant difference between 778 weight loss interventions and control interventions with respect to rates of miscarriage and IVF 779 conceptions. Well-designed RCTs should also shed light on the effect of weight loss on numbers 780 of oocytes retrieved and other parameters in IVF cycles, and on TTC, as well as the role of 781 interventions in couples. In men, improvements in sperm concentrations, motility and normal 782 morphology have been suggested, as well as in sperm DNA integrity, but further high quality 783 research is needed to confirm these findings and demonstrate improvement in live birth rates in 784 their partners. 785 
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Table 1. Types of interventions evaluated in studies of weight loss interventions and fertility in women and men who are overweight or 
obese. 
Reducing diet/healthy eating and exercise programme or advice 
DuvalDuval et al 2015 G RCT 
KarimzadehKarimzadeh et al 2010 RCT 
MoranMoran et al 2011 RCT 
MutsaertsMutsaerts et al 2016 RCT 
PalombaPalomba et al 2010 G RCT 
SimSim et al 2014 G RCT 
ClarkClark et al 1998 G Non-RCT 
CrosignaniCrosignani et al 2003 Cohort 
De Frène 2015 Cohort 
FaureFaure et al 2014 Cohort 
GalletlyGalletly et al 1996a G Cohort 
GalletlyGalletly et al 1996b G Cohort 
HakonsenHakonsen et al 2011 Cohort 
HollmanHollman et al 1996 Cohort 
KhaskheliKhaskheli et al 2013 Cohort 
MahoneyMahoney et al 2014 Cohort 
MillerMiller et al 2008 G Cohort 
SalamaSalama et al 2015 Cohort 
Reducing diet/healthy eating, weight loss drugs, and exercise programme or advice  
LegroLegro et al 2015 RCT 
LazurovaLazurova et al 2004 Non-RCT 
KortKort et al 2014 Cohort 
Reducing diet/health eating, or type of diet 
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BeckerBecker et al 2015 RCT 
MoranMoran et al 2003 RCT 
QublanQublan et al 2007 RCT 
Turner-McGrievyTurner-McGrievy et al 2014 RCT 
AliyevaAliyeva et al 1993 Non-RCT 
PalombaPalomba et al 2008 G Non-RCT 
AwartaniAwartani et al 2012 Cohort 
KiddyKiddy et al 1992 Cohort 
MavropoulosMavropoulos et al 2005 G Cohort 
ThomsonThomson et al 2009 Cohort 
TsagareliTsagareli et al 2006 Cohort  
Van DamVan Dam et al 2004 Cohort 
Behavioural therapy, including motivational interviewing 
KarlsenKarlsen et al 2013 Non-RCT 
KoningKoning et al 2015 C Non-RCT 
HomanHoman et al 2012 Cohort 
Exercise programme 
ThomsonThomson et al 2008 G RCT 
PalombaPalomba et al 2008  Non-RCT 
Orlistat 
KumarKumar et al 2014 RCT 
Metformin 
KarimzadehKarimzadeh et al 2010 RCT 
KumarKumar et al 2014 RCT 
QublanQublan et al 2007 RCT 
SonmezSonmez et al 2005 RCT 
LazurovaLazurova et al 2004 Non-RCT 
Acarbose 
SonmezSonmez et al 2005 RCT 
Detailed lifestyle questionnaire 
ChavarroChavarro et al 2012 C Cohort 
G, group intervention; C, couples were able to take part 
 
Table 2. Reproductive outcomes for women (lower numbers for ranking indicate better outcomes). 
Study ID Intervention 
arm 
 Pregnancies 
per 
participant 
% Live births 
per 
participant 
% Miscarriages 
per participant 
(fewer = better) 
% Miscarriages 
per pregnancy 
(fewer = 
better) 
% Improved 
ovulation per 
anovulatory 
participant 
% Improved 
menstrual 
irregularity / 
irregular menses 
per participant 
Time to 
conception per 
participant (less = 
better) 
  N Rank % Rank % Rank % Rank % Rank % Rank % Rank  
DuvalDuval et al 2015 Diet & exercise 24 1 79.2 2 62.5           
ClarkClark et al 1998 Diet & exercise 67 2 77.6 1 67.2 13 14.9 9 18.2 1 89.6     
KortKort et al 2014 Diet & exercise 52 3 65.4 4 48.1         4 226.57 
days for 
those with 
10&% 
weight loss 
MutsaertsMutsaerts et al 
2016 
Diet & exercise 280 4 63.9 3 53.2 12 14.6 12 22.9 17 42.4   3 Median 
7.2 
months 
(IQR 2.6, 
12.0) 
KhaskheliKhaskheli et al 
2013 
Diet & exercise 85 5 63.5 8 37.6 11 10.6 7 16.7       
GalletlyGalletly et al 
1996(b) 
Diet & exercise 58 6 58.6             
MoranMoran et al 2011 Diet & exercise 18 7 57.1 7 38.9           
KoningKoning et al 2015 Motivational 
interviewing 
102 8 53.9 5 47.1 2 2.0 2 3.6       
ChavarroChavarro et al 
2012 
Questionnaire 170 9 51.2             
AliyevaAliyeva et al 1993 Acupuncture 20 10 45.0       9 55.0 15 45.0   
SimSim et al 2014 Diet & exercise 26 11 44.4 6 44.4 14 18.5 14 41.7       
KumarKumar et al 2014 Orlistat 30 11 40.0       10 50.0     
MavropoulosMavropoulos 
et al 2005 
Low calorie 
ketogenic diet 
5 13 40.0             
Study ID Intervention 
arm 
 Pregnancies 
per 
participant 
% Live births 
per 
participant 
% Miscarriages 
per participant 
(fewer = better) 
% Miscarriages 
per pregnancy 
(fewer = 
better) 
% Improved 
ovulation per 
anovulatory 
participant 
% Improved 
menstrual 
irregularity / 
irregular menses 
per participant 
Time to 
conception per 
participant (less = 
better) 
  N Rank % Rank % Rank % Rank % Rank % Rank % Rank  
PalombaPalomba et al 2008 Exercise 20 14 35.0   7 5.0 5 14.3 5 65.0     
HomanHoman et al 2012 Motivational 
interviewing 
35 15 34.8   5 4.3 3 12.5       
AwartaniAwartani et al 
2012 
Weight 
reduction 
advised 
90 16 34.4             
QublanQublan et al 2007 Diet 24 17 33.3   4 4.2 3 12.5 10 50.0 11 61.9   
LegroLegro et al 2015 Diet & exercise 50 18 32.0 9 26.0 9 6.0 10 18.8 6 60.3     
CrosignaniCrosignani et al 
2003 
Diet & exercise 33 19 30.3 10 24.2     8 55.6 6 66.7   
AliyevaAliyeva et al 1993 Diet 60 20 30.0       14 46.7 8 63.3   
KiddyKiddy et al 1992 Very low calorie 
diet/Low calorie 
diet 
24 21 29.2 14 16.7 10 8.3 13 28.6   20 29.4   
HollmanHollman et al 1996 Diet & exercise 35 22 28.6 12 22.9 8 5.7 11 20.0   3 80.0   
LegroLegro et al 2015 Diet, exercise, 
oral 
contraceptive pill 
50 23 28.0 11 24.0 3 4.0 5 14.3 4 67.1     
QublanQublan et al 2007 Metformin 22 24 27.3   6 4.5 7 16.7 15 45.5 12 61.1   
KumarKumar et al 2014 Metformin 30 25 26.7       20 23.3     
BeckerBecker et al 2015 Diet 14 26 21.4 13 21.4           
KarimzadehKarimzadeh et 
al 2010 
Diet & exercise 75 26 20.0         6 66.7   
LazurovaLazurova et al 
2004 
Metformin 30 28 20.0         4 70.0   
MillerMiller et al 2008 Diet & exercise 12 29 16.7         1 83.3   
KarimzadehKarimzadeh et 
al 2010 
Metformin & 
clomiphene 
88 30 14.8         10 62.5   
DeFrene 2015 Diet & exercise 23 31 13.0             
KarimzadehKarimzadeh et 
al 2010 
Metformin 90 32 12.2         13 55.6   
SalamaSalama et al 2015 Mediterranean 
diet & exercise 
58 33 12.1         9 62.8   
Study ID Intervention 
arm 
 Pregnancies 
per 
participant 
% Live births 
per 
participant 
% Miscarriages 
per participant 
(fewer = better) 
% Miscarriages 
per pregnancy 
(fewer = 
better) 
% Improved 
ovulation per 
anovulatory 
participant 
% Improved 
menstrual 
irregularity / 
irregular menses 
per participant 
Time to 
conception per 
participant (less = 
better) 
  N Rank % Rank % Rank % Rank % Rank % Rank % Rank  
Turner-McGrievyTurner-
McGrievy et al 2014 
Low calorie diet 9 34 11.1       22 0.0     
PalombaPalomba et al 2008 Diet 20 35 10.0   1 0.0 1 0.0 19 25.0     
GalletlyGalletly et al 
1996(a) 
Exercise & advice 96 36 9.4             
MoranMoran et al 2003 High protein diet 14 37 8.7         21 26.1 1 4-5 weeks 
LazurovaLazurova et al 
2004 
Sibutramine, 
diet, exercise 
15 38 6.7         14 53.3   
ThomsonThomson et al 
2008 
Diet & aerobic 
exercise 
31 39 6.3       10 50.0 17 42.9   
MoranMoran et al 2003 Low protein diet 14 40 4.3         22 22.7 1 4-5 weeks 
ThomsonThomson et al 
2008 
Diet 30 41 3.3       10 50.0 24 21.4   
PalombaPalomba et al 2010 Diet & exercise, 
Clomiphene 
32 42 3.1       18 37.5 19 34.4   
ThomsonThomson et al 
2008 
Diet & aerobic & 
resistance 
exercise 
33 43 3.0       16 42.8 16 44.4   
Turner McGrievy 2014 Vegan diet 9 44 0       22 0.0     
SonmezSonmez et al 2005 Acarbose 15         2 86.7 5 69.2   
SonmezSonmez et al 2005 Metformin 15         3 80.0 2 80.0   
Van DamVan Dam et al 
2004 
Very low calorie 
diet 
15         6 60.0     
ThomsonThomson et al 
2009 
Diet 52         20 19.2 18 42.3   
PalombaPalomba et al 2010 Diet & exercise 32         21 12.5 25 12.5   
MahoneyMahoney et al 
2014 
Motivational 
interviewing, 
diet, exercise 
           23 22.2   
 6 
Table 3. Weight reduction outcomes for women (lower numbers for ranking indicate better outcomes). 
Study ID Intervention 
Arm 
 Mean Weight change (kg) Per 
Participant 
Mean BMI change (kg/m2) Per 
Participant 
Mean Waist Circumference change (cm) Per 
Participant 
  N Rank Change Rank Change Rank Change 
MavropoulosMavropoulos 
et al 2005 
Low calorie ketogenic diet 5 1 -12.34 ± 6.37 8 -4.0   
HollmanHollman et al 
1996 
Diet & exercise 35 2 -10.2 ± 7.9 10 -3.4 (median)   
ClarkClark et al 1998 Diet & exercise 67 3 -10.2 ± 4.3 9 -3.7 ± 1.6   
ThomsonThomson et al 
2008 
Diet & aerobic exercise 31 4 -10.1 ± 5.6   1 -11.7 ± 6.1 
KarlsenKarlsen et al 2013 Motivational interviewing 110 5 -9.3 11 -3.3   
ThomsonThomson et al 
2009 
Diet 52 6 -9.0 ± 0.8 (SEM)   4 -10.4 ± 0.9 (SEM) 
ThomsonThomson et al 
2008 
Diet  30 7 -8.6 ± 6.0   3 -10.8 ± 7.1 
ThomsonThomson et al 
2008 
Diet & aerobic & resistance 
exercise 
3 8 -8.6 ± 5.2   2 -11.0 ± 6.3 
MoranMoran et al 2003 High protein diet 14 9 -8.5 ± 1.1     
KumarKumar et al 2014 Orlistat 30 10 -7.81 ± 0.66% 4 -8.12 ± 6.71%   
KumarKumar et al 2014 Metformin 30 11 -7.78 ± 0.57% (SEM) 3 -8.40 ± 0.65% (SEM) 14 -2.68 ± 0.16% (SEM) 
KiddyKiddy et al 1992 Very low calorie diet/low calorie 
diet 
24 12 -6.9 ± 6.7     
MoranMoran et al 2003 Low protein diet 14 13 -6.9 ± 0.8 (SEM)     
SimSim et al 2014 Diet & exercise 26 14 -6.6 ± 4.6 14 -2.4 ± 1.6 6 -8.7 ± 5.6 
SalamaSalama et al 2015 Mediterranean diet & exercise 58 15 -6.3 ± 20.8 16 -2.37 ± 7.28 7 -6.45 ± 14.13 
LegroLegro et al 2015 Lifestyle 50 16 -6.2, 95% CI (-7.3, -5.3)   8 -6.3, 95% CI (-9.2, -3.4) 
GalletlyGalletly et al 
1996(b) 
Diet and exercise 58 17 -6.2 ± 4.5 13 -2.4 ± 1.7   
LegroLegro et al 2015 Diet, exercise, oral contraceptive 
pill 
50 18 -6.1, 95% CI (-7.0, -5.2)   9 -6.2, 95% CI (-9.1, -3.3) 
TsagareliTsagareli et al 
2006 
Very low calorie diet 6 19 -5.6; Range -8.2 to -5.3 17 -2.1; Range -1.8 to -3.2 5 -10.0; Range -7 to-14 
GalletlyGalletly et al 
1996(a) 
Diet & exercise 96 20 -5.2 ± 5.1     
BeckerBecker et al 2015 Diet 14 21 -4.51 ± 0.83 (SEM)   15 -1.31 ± 10.5 
PalombaPalomba et al 
2010 
Diet & exercise, Clomiphene 32 22 -4.42 ± 9.22 12 -2.64 ± 4.26 11 -4.92 ± 5.87 
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Study ID Intervention 
Arm 
 Mean Weight change (kg) Per 
Participant 
Mean BMI change (kg/m2) Per 
Participant 
Mean Waist Circumference change (cm) Per 
Participant 
  N Rank Change Rank Change Rank Change 
MutsaertsMutsaerts et al 
2016 
Diet & exercise 280 23 -4.4 ± 5.8 21 -1.3 (Median) 
IQR (-2.5, -0.07) 
  
KoningKoning et al 2015 Motivational interviewing 102 24 -4.3 ± 0.8 (SEM) 20 -1.4 ± 0.3 (SEM)   
PalombaPalomba et al 
2010 
Diet & exercise 32 25 -4.21 ± 8.56 15 -2.39 ± 3.54 12 -3.84 ± 6.35 
MoranMoran et al 2011 Diet & exercise 18 26 -3.8 ± 3.0 19 -1.4 ± 1.1 10 -5.3 ± 4.6 
MahoneyMahoney et al 
2014 
Motivational interviewing, diet, 
exercise 
9 27 -3.18 ± 2.27 24 -0.7 ± 7.31   
Turner-McGrievyTurner-
McGrievy et al 2014 
Vegan diet 9 28 -2.1 ± 3.5     
Turner-McGrievyTurner-
McGrievy et al 2014 
Low calorie diet 9 29 -0.4 ± 0.9     
ChavarroChavarro et al 
2012 
Questionnaire 170 30 &0.3 (Median) 
IQR (-0.1, 1.8) 
    
KortKort et al 2014 Diet & exercise 52   1 -13.89% ± 3.71% in 17 with 10&% weight loss -3.79% ± 3.98% in 35 with <10% weight loss 
  
KhaskheliKhaskheli et al 
2013 
Diet & exercise 85   2 -9.6 ± 1.23   
LazurovaLazurova et al 
2004 
Sibutramine, diet, exercise 15   5 -4.6 ± 4.2 (SEM)   
QublanQublan et al 2007 Diet 24   6 -4.8   
QublanQublan et al 2007 Metformin 22   7 -4.1   
MillerMiller et al 2008 Diet & exercise 12   18 -2.06 ± 0.51 (SEM)   
SonmezSonmez et al 2005 Acarbose 15   22 -1.1 ± 2.78   
LazurovaLazurova et al 
2004 
Metformin 30   23 -0.85 ± 0.38 (SEM)   
SonmezSonmez et al 2005 Metformin 15   25 -0.3 ± 2.47   
HomanHoman et al 2012 Motivational interviewing 35  “47% of the overweight 
participants had a 
modest loss of between 
1 and 5 kg (not 
statistically significant)” 
   -3.8 in ½ of those attending 
follow-up and not pregnant 
DuvalDuval et al 2015 Diet & exercise 24  10/24 had ≥ 5% weight 
loss 
   12/24 had ≥ 5cm reduction 
(compared to 11/31 in control 
group) 
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Study ID Intervention 
Arm 
 Mean Weight change (kg) Per 
Participant 
Mean BMI change (kg/m2) Per 
Participant 
Mean Waist Circumference change (cm) Per 
Participant 
  N Rank Change Rank Change Rank Change 
(compared to 11/31 in 
control group) 
KarimzadehKarimzadeh et 
al 2010 
Diet & exercise 75      Significantly lower waist 
circumference (P=0.001) in the 
lifestyle group than in the 
clomiphene, metformin, and 
clomiphene/metformin groups 
AliyevaAliyeva et al 1993 Diet 60  “30-40% decrease in 
body weight in 2-4 
months” 
    
AliyevaAliyeva et al 1993 Acupuncture 20  “Slower rate and extent 
of weight reduction: 7-
9 months” 
    
AwartaniAwartani et al 
2012 
Weight reduction advised 90    23/90 reduced their 
BMI below 35; 65/90 
did not 
  
CrosignaniCrosignani et al 
2003 
Diet & exercise 33      Those with 5% weight loss had 
mean waist circumference 94 
cm, SD 9 
Those with 10% weight loss had 
mean 86, SD 7 
Van DamVan Dam et al 
2004 
Very low calorie diet 15  14/15 loss at least 10% 
of body weight 
    
PalombaPalomba et al 
2008 
Exercise 20  Ovulatory (n=13):  
Mean -5.6%, SD 1.6% 
Anovulatory (n=7):  
Mean -2.0% ,SD 0.2% 
 Ovulatory (n=13): 
Mean -10.0%, SD 3.7% 
Anovulatory (n=7): 
Mean -1.4%, SD 2.1% 
 Ovulatory (n=13): 
Mean -9.6%, SD 2.1% 
Anovulatory (n=7): 
Mean -2.5%, -SD 2.9% 
PalombaPalomba et al 
2008 
Diet 20  Ovulatory (n=5):  
Mean -10.5%, SD 4.1% 
Anovulatory (n=15): 
 Mean -2.3%, SD 3.1% 
 Ovulatory (n=5): 
Mean -15.4%, SD 3.9% 
Anovulatory (n = 15): 
Mean -4.0%, SD 5.2% 
 Ovulatory (n=5): 
Mean -9.4%, SD 2.5% 
Anovulatory (n=15): 
Mean -2.8%, SD 3.1% 
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Table 4. Reproductive and weight outcomes for infertile men. 
 FaureFaure et al 2014 
N=8 
HakonsenHakonsen et al 2011 
 N=27 of 44 at follow-up  
Clinical pregnancy rate 8/8  
Live birth rate 8/8  
Improvement in sperm DNA 
integrity 
6/6 consenting to semen 
analysis upon completion 
 
Change in sperm 
concentration 
(million/ml) 
 
Group 1: Weight loss 3.5-
12.1% 
 
Group 2: Weight loss 12.2-
17.1% 
 
Group 3: Weight loss 17.2-
25.4% 
 Group 1 (n=9) 
Mean -11 
95% CI -49, 27 
 
Group 2 (n=9) 
Mean +19 
95% CI -23, 61 
 
Group 3 (n=9) 
Mean +17 
95% CI -24, 58 
Change in sperm motility 
(% motile) 
 Group 1 (n=8) 
Mean -2 
95% CI -15, 11 
 
Group 2 (n=9) 
Mean +4 
95% CI -10, 18 
 
Group 3 (n=9) 
Mean +11 
95% CI -3, 25 
Change in normal sperm 
morphology 
(% normal forms) 
 Group 1 (n=9) 
Mean 0 
95% CI -2, 4 
 
Group 2 (n=9) 
Mean +1 
95% CI -3, 4 
 
Group 3 (n=9) 
Mean +4 
95% CI 1, 7 
Change in weight (kg) Mean -4.40 
SD 5.00 
Median -22 
Range -4 to –39 
Change in BMI 
(kg/m2) 
Mean -1.22 
SD 1.38 
 
Change in Waist circumference 
(cm) 
Mean -8.50 
SD 7.89 
 
 
